Lys328

Site Information
ALAPstMkIkIIAPP SwissProt Entrez-Gene
Blast this site against: NCBI SwissProt PDB
Site Group ID: 466093

In vivo Characterization
Methods used to characterize site in vivo:	mass spectrometry ( 1 , 2 , 3 )
Relevant cell line - cell type - tissue:	colon ( 1 ) , liver ( 1 , 2 ) , MEF (fibroblast) [HDAC6 (mouse), heterozygous knockout] ( 3 )

Upstream Regulation
Treatments:	gut microbiota ( 1 )

References
1	Simon GM, Cheng J, Gordon JI (2012) Quantitative assessment of the impact of the gut microbiota on lysine epsilon-acetylation of host proteins using gnotobiotic mice. Proc Natl Acad Sci U S A 109, 11133-8 22733758 Curated Info
2	Li Y (2009) CST Curation Set: 7494; Year: 2009; Biosample/Treatment: tissue, liver/0.1% serum; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: acK Antibodies Used to Purify Peptides prior to LCMS: Acetylated-Lysine (Ac-K2-100) Rabbit mAb Cat#: 9814, PTMScan(R) Acetyl-Lys Motif (Ac-K) Immunoaffinity Beads Cat#: 1989 Curated Info
3	Li Y (2006) CST Curation Set: 1907; Year: 2006; Biosample/Treatment: cell line, MEF[HDAC6(heterozygous knockout)]/untreated; Disease: -; SILAC: -; Specificities of Antibodies Used to Purify Peptides prior to LCMS: acK Antibodies Used to Purify Peptides prior to LCMS: Acetylated-Lysine (Ac-K2-100) Rabbit mAb Cat#: 9814, PTMScan(R) Acetyl-Lys Motif (Ac-K) Immunoaffinity Beads Cat#: 1989 Curated Info